Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
04/2014
04/15/2014US8697697 Pyrazole derivatives as ERK inhibitors
04/15/2014US8697694 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
04/15/2014US8697064 Nitrogenated derivatives of pancratistatin
04/15/2014CA2786089C Nitrogen-containing heterocyclic compound and agricultural fungicide
04/15/2014CA2557495C Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
04/10/2014WO2014055618A1 Solid state forms of hiv inhibitor: hemi-succinate of (2s)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid)
04/10/2014WO2014055603A1 Process for the preparation of an hiv integrase inhibitor
04/10/2014WO2014055548A1 Anti-fibrotic pyridinones
04/10/2014WO2014054898A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same
04/10/2014WO2014053666A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/10/2014US20140100240 Natural product derivatives with antiprotozoal activity
04/09/2014EP2716639A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/09/2014EP2714677A1 Pyridine-and pyrazine derivatives
04/09/2014CN103717593A Compositions and methods for modulating a kinase
04/09/2014CN103717574A Novel compounds and compositions for the inhibition of nampt
04/09/2014CN103709172A Substituted furan-piperidine derivative and application thereof
04/09/2014CN103709151A Spiro compounds adopted as hepatitis C inhibitor, and applications of spiro compounds in preparation of drugs
04/09/2014CN102483572B Photopolymerizable composition, color filter, method for producing same, solid-state image pickup element, liquid crystal display device, lithographic printing original plate, and novel compound
04/09/2014CN102180885B Sanguinarine alcoholate and chelerythrine alcoholate and preparation method and application thereof in animal acaricidal drugs
04/08/2014US8691864 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
04/08/2014US8691832 Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
04/08/2014CA2641776C Pyrazoloquinolones are potent parp inhibitors
04/08/2014CA2621443C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
04/03/2014WO2014051077A1 Method for producing nitrogen-containing heterocyclic compound of high purity
04/03/2014WO2014050613A1 Method for producing nitrogenated heterocyclic n-oxide compound
04/03/2014WO2014049488A1 Benzamide and heterobenzamide compounds
04/03/2014WO2014048072A1 Spiro ring compounds as hepatitis c virus (hcv) inhibitors
04/03/2014WO2014015056A3 Anti-mucus drugs and uses therefor
04/03/2014US20140094610 Process for the preparation of an hiv integrase inhibitor
04/03/2014US20140094609 Process for the preparation of an hiv integrase inhibitor
04/03/2014US20140094486 Solid state forms of hiv inhibitor
04/03/2014US20140094485 Solid state forms of hiv inhibitor
04/02/2014EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
04/02/2014CN103703003A Novel compounds for organic electronic material and organic electroluminescent device using the same
04/02/2014CN103694247A Compound Chaetomugilide A and preparation method and application thereof
04/02/2014CN102827246B Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof
04/02/2014CN102718771B Indolocarbazole-based fluorescence probe and preparation method and use thereof
04/01/2014US8686148 Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
04/01/2014US8686134 Ionic liquids
04/01/2014US8686002 Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
04/01/2014US8685995 Treatment with opioid antagonists and mTOR inhibitors
04/01/2014US8685958 Therapeutic agents
03/2014
03/27/2014WO2014047393A1 N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds as notch inhibitors
03/27/2014WO2014047392A1 Fluoroalkyl-1,4-benzodiazepinone compounds
03/27/2014WO2014044615A1 Dihydroquinolinone derivatives
03/27/2014WO2014044399A1 New spiroepoxide tetrahydrobenzotriazoles and their use as metap-ii inhibitors
03/27/2014WO2012154676A9 Partially saturated tricyclic compounds and methods of making and using same
03/27/2014US20140088130 Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof
03/27/2014US20140088082 Inhibitors of the plasmodial surface anion channel as antimalarials
03/27/2014US20140088078 Partially Saturated Tricyclic Compounds and Methods of Making and Using Same
03/26/2014EP2711367A1 New spiroepoxide tetrahydrobenzo-triazoles and -imidazoles and their use as MetAP-II inhibitors
03/26/2014EP2710010A1 Novel crystalline salts of asenapine
03/26/2014EP2710009A1 Novel crystalline asenapine hydrochloride salt forms
03/26/2014EP2710008A1 Novel crystalline salts of asenapine with organic di-acids and tri-acids
03/26/2014EP2709616A1 A stable micronised monoclinic form of asenapine maleate and its synthesis
03/26/2014EP2709615A1 Monoclinic crystalline form of asenapine maleate with a specific particle size distribution
03/26/2014EP2709451A1 N-linked lactam m1 receptor positive allosteric modulators
03/26/2014CN103687860A Heterocyclic amide derivatives as P2X7 receptor antagonists
03/26/2014CN103666452A Methylbenzofuran quinoline type biological probe, and preparation method and application thereof
03/26/2014CN103664996A Indole derivative and preparation method thereof
03/26/2014CN103664975A Method of extracting camptothecin in nothapodytes pittosporoides
03/26/2014CN103664974A Aryl [a] indole [2,3-g] quinolizine compound as well as preparation method, pharmaceutical composition and application thereof
03/26/2014CN103664973A Spiro-oxindole compounds and their use as therapeutic agents
03/26/2014CN103664972A Derivatives and salts of diamino dihydrotriazine, and preparation method, composition and application thereof
03/26/2014CN103664971A Naphthalimide modified rhodamine B derivative as well as preparation method and application thereof
03/26/2014CN103664970A Salt of dehydroxyl narciprimine derivate
03/26/2014CN103664969A Narciprimine derivative salt
03/26/2014CN103664968A Salts of lycoris radiata lactone derivatives
03/26/2014CN103664734A Heterocyclic hydroxamic acid compound as well as pharmaceutical composition and application thereof
03/25/2014US8680113 BMI-1 protein expression modulators
03/25/2014US8680111 Macrocyclic derivatives for the treatment of diseases
03/25/2014US8680079 Tetrahydro-imidazo [1,5-A] pyridyin derivatives as aldosterone synthase inhibitors
03/25/2014CA2541086C Process for making amide acetals
03/20/2014WO2014042263A1 Novel renin inhibitor
03/20/2014WO2014041175A1 Novel inhibitor compounds of phosphodiesterase type 10a
03/20/2014US20140080837 Sanglifehrin Derivatives and Methods for Their Production
03/20/2014US20140080823 Spirocyclic derivatives as histone deacetylase inhibitors
03/20/2014US20140080804 Novel 6-arylamino pyridone carboxamide as mek inhibitors
03/20/2014US20140080756 2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5]nonane derivatives
03/19/2014EP2708541A1 5,6-dihydroxy-isoindole derivatives as linkers for oligomer solid phase synthesis
03/19/2014CN103649094A Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
03/19/2014CN103649082A Pyridine derivative and bace-1 inhibitor containing same
03/19/2014CN103649080A Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103648497A Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
03/19/2014CN103642299A Application of benzoheterocycle alkaloids in preparation of marine organism stain preventing coatings
03/19/2014CN103641839A Compounds with anti-tumor effect in zephyranthes candida and separation preparation method and application thereof
03/19/2014CN103641834A Pyrrolobenzodiazepine compounds, and preparation method and application thereof
03/19/2014CN103641832A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641831A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641830A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641768A Phenylindole high iodine salt compound, and preparation method and use thereof
03/19/2014CN102775417B Sanguinarine alcoholate, preparation method and application thereof in plant bactericide drug
03/19/2014CN101550072B Effective component of cogongrass rhizome and preparation method thereof
03/18/2014US8674104 Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof
03/18/2014US8674103 Lyotropic liquid crystal systems based on aromatic tetracarboxylic bisbenzoimidazole derivatives and methods for making
03/18/2014US8673936 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
03/18/2014US8673931 Bicyclic heterocyclic spiro compounds
03/18/2014US8673908 Kynurenine production inhibitor
03/18/2014US8673905 Imidazo pyrazines
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 298